Stocks › CC

Chemours Co

CC·NYSE·United States United States·USD
$10.88
-0.92 (-7.80%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CC
Chemours Co · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CC by members of U.S. Congress · 10 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA CCChemours Co · Common Stock Sale
$1,001 - $15,000
Feb 5, 2024 Jan 10, 2024 Filing ↗
Michael C. BurgessMichael C. BurgessHouse · R · TX CCChemours Co · Stock Purchase
$15,001 - $50,000
Sep 5, 2023 Aug 9, 2023 Filing ↗
Michael C. BurgessMichael C. BurgessHouse · R · TX CCChemours Co · Stock Purchase
$15,001 - $50,000
Jul 18, 2023 Jul 6, 2023 Filing ↗
Michael C. BurgessMichael C. BurgessHouse · R · TX CCChemours Co · Stock Sale
$1,001 - $15,000
Jul 18, 2023 Jul 6, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA CCChemours Co · Common Stock Purchase
$1,001 - $15,000
Dec 6, 2022 Nov 3, 2022 Filing ↗
Tammy DuckworthTammy DuckworthSenate · D · IL CCChemours Co · Stock Sale
$1,001 - $15,000
Nov 7, 2017 Oct 10, 2017 Filing ↗
Richard L. HannaRichard L. HannaHouse · R · NY CCChemours Co · Stock Sale
$1,001 - $15,000
Nov 9, 2015 Oct 1, 2015 Filing ↗
George HoldingGeorge HoldingHouse · R · NC CCChemours Co · Stock Sale
$1,001 - $15,000
Sep 22, 2015 Aug 7, 2015 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH CCChemours Co · Stock Sale
$1,001 - $15,000
Jul 22, 2015 Jul 2, 2015 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH CCChemours Co · Stock Sale
$1,001 - $15,000
Jul 22, 2015 Jul 2, 2015 Filing ↗

Whale Activity

Position changes in CC reported for 2026-09-30 by 522 institutional filers
Increased: 128New: 55Held: 107Decreased: 131Closed: 76No prior filing: 25
  • Increased128
  • New55
  • Held107
  • Decreased131
  • Closed76
  • No prior filing25
FilerSharesValueChange
BlackRock, Inc.22.5M$305.6Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC10.9M$148.1Mincreased
VANGUARD CAPITAL MANAGEMENT LLC6.8M$92.2Mincreased
STATE STREET CORP6.1M$82.5Mdecreased
JPMORGAN CHASE & CO5.8M$80.2Mincreased
COOPER CREEK PARTNERS MANAGEMENT LLC5.6M$76.0Mincreased
AMERIPRISE FINANCIAL INC4.6M$62.7M—
GEODE CAPITAL MANAGEMENT, LLC3.8M$51.2Mdecreased
D. E. Shaw & Co., Inc.3.5M$47.5Mincreased
GOLDMAN SACHS GROUP INC2.8M$38.5Mincreased
Jefferies Financial Group Inc.2.7M$37.2Mincreased
DIMENSIONAL FUND ADVISORS LP2.6M$34.8Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CC insiders, by quarter · Form 4
-50.0K-25.0K025.0K50.0K2025 Q1: 02025 Q12025 Q2: 25.7K2025 Q22025 Q3: 4,0682025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 31.5K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

1,053 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Will DavidChief Accounting Officer Tax withholding −2,426 $15.24 $37K Aug 12, 2026 Form 4 ↗
Familiar Calderon GerardoSee Remarks Purchase +1,935 $15.53 $30K Aug 12, 2026 Form 4 ↗
Dignam DeniseChief Executive Officer · Director Purchase +3,378 $14.95 $51K Aug 11, 2026 Form 4 ↗
Cowan AlisterDirector Purchase +13.0K $15.62 $203K Aug 7, 2026 Form 4 ↗
Foley Michael RobertSee Remarks Purchase +1,934 $15.51 $30K Aug 7, 2026 Form 4 ↗
Martinko Joseph T.See Remarks Purchase +1,940 $15.47 $30K Aug 7, 2026 Form 4 ↗
CRANSTON MARY BDirector Purchase +6,000 $15.83 $95K Aug 7, 2026 Form 4 ↗
HOSTETTER SHANEChief Financial Officer Purchase +3,350 $14.94 $50K Aug 6, 2026 Form 4 ↗
HOSTETTER SHANEChief Financial Officer Tax withholding −3,087 $15.11 $47K Aug 6, 2026 Form 4 ↗
Martinko Joseph T.See Remarks Tax withholding −663 $16.61 $11K Aug 1, 2026 Form 4 ↗
Dignam DeniseChief Executive Officer · Director Tax withholding −477 $16.61 $8K Aug 1, 2026 Form 4 ↗
Wellman Kristine MSVP, GC & Corp. Secretary Tax withholding −391 $16.61 $6K Aug 1, 2026 Form 4 ↗
Familiar Calderon GerardoSee Remarks Tax withholding −943 $16.61 $16K Aug 1, 2026 Form 4 ↗
CRANSTON MARY BDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
Turner Leslie MDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
Fletcher PamelaDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
Cowan AlisterDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
MATHER COURTNEYDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
Kane Erin NDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗
SATTERTHWAITE LIVINGSTONDirector Grant / award +7,182 $0.00 $0 May 6, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CC · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Small-Cap ETF
iShares Trust
9.1M$185.9M0.17%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
4.8M$98.2M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
3.9M$81.0M0.10%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
3.5M$70.8M0.04%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
2.2M$44.8M0.07%Jun 30, 2026
Columbia Select Mid Cap Value Fund
COLUMBIA FUNDS SERIES TRUST
2.3M$35.5M1.06%Aug 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.7M$35.4M0.04%Jun 30, 2026
Avantis U.S. Small Cap Value ETF
American Century ETF Trust
2.1M$33.1M0.11%Aug 31, 2026
JPMorgan Large Cap Value Fund
JPMorgan Trust II
1.6M$32.4M0.63%Jun 30, 2026
iShares Russell 2000 Growth ETF
iShares Trust
1.4M$29.1M0.19%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list CC's shares (CUSIP 163851108), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming chemours as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q1: $1.3M2023 Q2: $515K2023 Q3: $430K2023 Q4: $690K20232024 Q1: $480K2024 Q2: $690K2024 Q3: $695K2024 Q4: $540K20242025 Q1: $775K2025 Q2: $970K2025 Q3: $540K2025 Q4: $580K20252026 Q1: $750K2026 Q2: $570K2026 Q3: $570K2026
  • THE CHEMOURS COMPANYTHE CHEMOURS COMPANY · 2026 Q3 · CHM, TRA, TRD, TAX$330K
    Filing ↗
  • HOLLAND & KNIGHT LLPTHE CHEMOURS COMPANY · 2026 Q3 · MAN, ENV, TAX, ENG$90K
    Filing ↗
  • BOSE PUBLIC AFFAIRS GROUPTHE CHEMOURS COMPANY · 2026 Q3 · ENV, TRD, CHM$60K
    Filing ↗
  • STRATEGIC MARKETING INNOVATIONSTHE CHEMOURS COMPANY · 2026 Q3 · ENG, DEF$90K
    Filing ↗
  • THE CHEMOURS COMPANYTHE CHEMOURS COMPANY · 2026 Q2 · CHM, TRA, TRD, TAX$340K
    Filing ↗

Government Contracts

Federal awards to Chemours Co · USAspending

No federal contract awards found for Chemours Co.

U.S. Patents

Recent USPTO applications naming Chemours Co

No USPTO patent applications found for Chemours Co.

Annual Financials

From CC's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$5.81B$5.78B$6.08B$6.83B$6.34B
Net income-$386.0M$69.0M-$253.0M$578.0M$608.0M
Diluted EPS-$2.57$0.46-$1.70$3.65$3.60
Operating cash flow$264.0M-$633.0M$556.0M$755.0M$814.0M
Cash and equivalents$670.0M$713.0M$1.20B$1.10B$1.45B
Total assets$7.38B$7.51B$8.24B$7.64B$7.55B
Total liabilities$7.13B$6.94B$7.52B$6.53B$6.47B
Shareholders' equity$250.0M$571.0M$721.0M$1.11B$1.08B

As Chemours Co tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in CC's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02, 9.01Officer / director changeNov 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 2, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureSep 10, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureSep 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureJun 24, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
    EDGAR ↗

About Chemours Co

From SEC EDGAR company records

Overview The Chemours Company (herein referred to as “we”, “us”, or “our”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide (“TiO2”) pigment and industrial fluoropolymer resins. We manage and report our operating results through three principal reportable segments: Thermal &…

Industry (SIC 2800)Chemicals & Allied Products
SectorMaterials
HeadquartersWILMINGTON, DE
IncorporatedDE
Former namesChemours Company, LLC